Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05231 (
interleukin-6
)
23,907
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In vivo studies have shown that cancer-associated skeletal muscle wasting (cachexia) is mediated by two cytokines, tumor necrosis factor-alpha (TNF) and
interleukin-6
(
IL-6
). It has been unclear from these studies whether TNF exerts direct effects on skeletal muscle and/or whether these effects are mediated via
IL-6
. Previous studies from our laboratory have shown that TNF induces
IL-6
mRNA expression in cultured skeletal muscle cells. To further investigate the relationship between TNF and
IL-6
, the effects of TNF and
IL-6
on protein and DNA dynamics in murine C2C12 skeletal myotube cultures were determined. At 1000 U/ml, TNF induced 30% increases in protein and DNA content. The effects of TNF on protein accumulation were inhibited by aphidicolin, an inhibitor of DNA synthesis.
IL-6
mimicked the effects of TNF on C2C12 cultures, inducing a 32% increase in protein accumulation and a 71% increase in the rate of protein synthesis.
IL-6
also decreased expression of mRNA for several proteolytic system components, including ubiquitin 2.4 kb (51%) and 1.2 kb (63%), cathepsin B (39%) and
m-calpain
(47%), indicating that
IL-6
acts on both protein synthesis and degradation. Incubation of murine C2C12 myotube cultures with TNF (1000 U/ml) in the presence of a polyclonal mouse anti-
IL-6
antibody resulted in an abolishment of the effects of TNF on protein synthesis, but did not inhibit TNF-induced stimulation of DNA synthesis. These findings indicate that the effects of TNF on muscle protein synthesis are mediated by
IL-6
, but that TNF exerts
IL-6
-independent effects on proliferation of murine skeletal myoblasts.
...
PMID:Tumor necrosis factor-alpha exerts interleukin-6-dependent and -independent effects on cultured skeletal muscle cells. 1185 80
Motor nerve injury by L5 ventral root transection (L5-VRT) initiates
interleukin-6
(
IL-6
) up-regulation in primary afferent system contributing to neuropathic pain. However, the early upstream regulatory mechanisms of
IL-6
after L5-VRT are still unknown. Here, we monitored both the activity of calpain, a calcium-dependent protease suggested as one of the earliest mediators for cytokine regulation, and the expression of
IL-6
in bilateral L4-L6 dorsal root ganglias (DRGs) soon after L5-VRT. We found that the protein level of
calpain-2
in DRGs, but not calpain-1 was increased transiently in the first 10 min(-1)h ipsilaterally and 20 min(-1)h contralaterally after L5-VRT, long before mechanical allodynia was initiated (5-15 h ipsilaterally and 15 h(-1)d contralaterally). The early activation of calpain evaluated by the generation of spectrin breakdown products (SBDP) correlated well with
IL-6
up-regulation in bilateral DRGs. Double immunofluorescence staining revealed that almost all the
calpain-2
positive neurons expressed
IL-6
, indicating an association between
calpain-2
and
IL-6
. Inhibition of calpain by pre-treatment with MDL28170 (25mg/kg, i.p.) attenuated the rat mechanical allodynia and prevented the early up-regulation of
IL-6
following L5-VRT. Addition of exogenous
calpain-2
onto the surface of left L5 DRG triggered a temporal allodynia and increased
IL-6
in bilateral DRGs simultaneously. Taken together, the early increase of
calpain-2
in L5-VRT rats might be responsible for the induction of allodynia via up-regulating
IL-6
in DRG neurons.
...
PMID:Calpain-2 contributes to neuropathic pain following motor nerve injury via up-regulating interleukin-6 in DRG neurons. 2515 5